Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Possible Safety Issue Pauses Ely Lilly COVID-19 Antibody Study

Red and gray 3D model of COVID-19. Looks like a sphere with red trees on it.
The Florida Channel
Leon County Judge John Cooper on June 30, 2022, in a screen grab from The Florida Channel.

Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly.

Lilly confirmed Tuesday that the study had been paused out of caution and said safety is its top concern. The company would not say more about what led to this step and the U.S. government agency sponsoring the study would not immediately comment.

The antibody drug is similar to a treatment President Donald Trump recently received.

The pause comes a day after a Johnson & Johnson coronavirus vaccine study was paused to allow investigation of a possible safety issue.